Compare FERG & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FERG | HLN |
|---|---|---|
| Founded | 1887 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Miscellaneous | Package Goods/Cosmetics |
| Sector | Miscellaneous | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8B | 41.7B |
| IPO Year | N/A | N/A |
| Metric | FERG | HLN |
|---|---|---|
| Price | $228.12 | $9.97 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 1 |
| Target Price | ★ $250.07 | N/A |
| AVG Volume (30 Days) | 1.6M | ★ 10.5M |
| Earning Date | 12-09-2025 | 07-31-2025 |
| Dividend Yield | 1.57% | ★ 1.84% |
| EPS Growth | 18.63 | ★ 41.64 |
| EPS | ★ 9.88 | 0.23 |
| Revenue | ★ $31,159,000,000.00 | $15,096,588,575.00 |
| Revenue This Year | $7.38 | $1.51 |
| Revenue Next Year | $5.90 | $4.67 |
| P/E Ratio | ★ $22.89 | $43.02 |
| Revenue Growth | ★ 4.92 | N/A |
| 52 Week Low | $146.00 | $8.71 |
| 52 Week High | $256.93 | $11.42 |
| Indicator | FERG | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 62.53 |
| Support Level | $221.50 | $9.68 |
| Resistance Level | $232.11 | $9.65 |
| Average True Range (ATR) | 5.47 | 0.15 |
| MACD | -1.65 | 0.03 |
| Stochastic Oscillator | 20.94 | 98.51 |
Ferguson distributes plumbing and HVAC products to North American repair, maintenance and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 36,000 suppliers. Ferguson engages customers through approximately 1,800 North American branches, over the phone, online, and in residential showrooms. According to Modern Distribution Management, Ferguson is the largest plumbing distributor and second-largest HVAC distributor (next to Watsco) in North America. The firm sold its UK business in 2021 and is now solely focused on the North American market.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.